Valenta considers innovations and development of new effective medicines as a key point of its work and integral part of effective business-strategy.
We actively invest in R&D and products portfolio development as well as in medical projects and healthcare innovations.
Valenta conducts scientific research in such therapeutic areas as neurology, urology, gastroenterology, immunology, virusology, antibacterial therapy and others.
We develop new medicines to improve Russian patients’ quality of life. This is achieved on the basis of evidence-based, high clinical efficacy with minimum risk of side effects.
We carefully analyse needs of national healthcare and address them with satisfying innovative solutions.
We focus on the R&D projects that will benefit both - as many Russian people as possible and our business development.